Despite progress made in cancer immunotherapy, some patients don’t respond to these treatments or they stop responding after a period of time. Eikon Therapeutics’ lead drug candidate could address these
Hair loss remains an area lacking biotechnology innovation. The drugs currently available are older products offering limited efficacy. Some of them cannot be used by women. Veradermics aims to shake
People have been riding the GLP-1 wave to achieve quick and significant weight loss. But given the drug’s effect on controlling type 2 diabetes, it’s no surprise that DexCom CEO
The healthcare startup world spawned a new unicorn this week, with Palo Alto-based virtual care provider Midi Health closing a $100 million Series D financing round that took its valuation
Included Health, a navigation and virtual care company, is launching into the insurance space with its alternative plan design for employers, the company announced last week. The San Francisco-based company
Providers’ rapid adoption of AI is pushing payers to accelerate their own use of administrative AI tools, with health plans looking for ways to keep pace and manage the growing
Far too often in healthcare, known vulnerabilities remain unpatched due to persistent resistance to patching. Many hospitals and providers identify legacy infrastructure and compatibility issues as pain points, and as
About 50 million people in the U.S. are affected by autoimmune disease, and about 80% of them are women. When women give birth, they often experience significant hormonal changes that
This could be the biggest week for biotech IPOs in years — even if the government remains shuttered temporarily. Government funding lapsed this past Saturday, sparking a partial government shutdown
Welcome back to another episode of MedCity FemFwd, a podcast dedicated to exploring the breakthroughs and challenges in women’s health. In this episode, we’re joined by Anna Jeter, co-founder and
